|
1501 E. Woodfield Rd., Ste. 300 E. Schaumburg, IL 60173-5837 IL Tel. 847-413-2075 Toll Free 888-386-1300 Fax 800-743-7082 |
Type: Subsidiary
On the web:
http://www.appdrugs.com
Your eyes are getting heavy. You're getting sleepy. No hypnotist here, just APP Pharmaceuticals, a company that develops, makes, and markets anesthetics and other injectable drugs. Specializing in generics, APP's critical care products segment includes market-leading general anesthetic Diprivan and blood thinner Heparin. Other product segments focus on injectable oncology treatments and drugs that fight ear, heart, respiratory tract, skin, and sinus infections. APP markets through a direct sales force and often sells through group purchasing organizations to customers that include hospitals, long-term care facilities, and clinics in North America. In 2008 the company was acquired by Germany's Fresenius.
Officers:
Chairman: Patrick Soon-Shiong
President and CEO: Thomas H. Silberg
EVP and COO: Frank Harmon
Competitors:
Baxter International
Hospira
Teva Pharmaceuticals USA
